OneTick, an international research initiative coordinated by the Medical University of Bialystok, the aim of which is to combat tick-borne diseases in urban and suburban environments, has received funding from the EU's MSCA Staff Exchanges 2024 programme.
Scientists have patented innovative implantable biomaterials - composites for the treatment of bone defects and for use in regenerative medicine. The patent was granted by the European Patent Office (EPO) for 'Multifunctional composite implantable materials for filling bone defects and regenerating bone tissue', the University of Gdańsk reports.
Polish experts have developed a system that detects depression, anxiety and other disorders based on eye movements in just 10 seconds. The accuracy currently reaches 70 percent, but researchers see the possibility of increasing it further.
Scientists from three universities in Gdańsk have developed a new crystalline form of chlordiazepoxide, a drug for anxiety and insomnia. According to team leader Professor Marek Wesołowski from the Medical University of Gdańsk, the advantage of the invention is the simple and green method of obtaining the drug.
A nanosecond electrical pulse and a calcium ion can be combined to create an effective, selective and less toxic method of destroying cancer cells compared to traditional therapies. Scientists and doctors from the Wroclaw Medical University use nanosecond calcium electroporation.
A device for controlling a computer with brain activity will be tested on the International Space Station. Scientists will check how microgravity affects blood flow in the brains of astronauts and human-machine communication.
PTSD symptoms are linked to higher blood insulin levels, a study by researchers from the University of Silesia shows. This may be the first step to insulin resistance and then diabetes. Early detection and treatment of PTSD may therefore be a way to avoid other serious health problems in the future.
Polish scientists have taken a step towards explaining the mysterious relationship between low lipoprotein (a) circulating in the blood and an increased risk of developing type 2 diabetes. Although numerous observational studies have long suggested the existence of this relationship, no one has previously been able to explain the mechanisms behind it.
Researchers from the International Institute of Molecular and Cell Biology in Warsaw (IIMCB) have discovered a new mechanism that improves the efficiency of mRNA-based therapies. Their findings have just appeared in the prestigious journal Nature.
If five risk factors were eliminated from each patient: hypertension, lipid disorders, diabetes, smoking, and overweight or obesity, the risk of heart attack or stroke would decrease by 90 percent, says Professor Krzysztof J. Filipiak, cardiologist.